Chong-Jian Zhang

Statistics

Publications

Citations

H-Index

Active since

2024

Affiliations

Henan University Huaihe Hospital and Huaihe Clinical Institute(Current)

Chong-Jian Zhang is an author at Henan University Huaihe Hospital and Huaihe Clinical Institute specializing in pertuzumab therapy, her2-positive breast cancer therapy, and neoadjuvant therapy.

Publications per year

2024–2024

Publications

De-escalated neoadjuvant weekly nab-paclitaxel with trastuzumab and pertuzumab versus docetaxel, carboplatin, trastuzumab, and pertuzumab in patients with HER2-positive early breast cancer (HELEN-006): a multicentre, randomised, phase 3 trial

Xiuchun Chen, Dechuang Jiao, Jianghua Qiao et al. · The Lancet Oncology · 2024 · 33 citations

Medicine, Oncology, Pharmacology +16

1–1 of 1